Conavi Medical Corp.
CNVIF
$0.26
$0.00461.80%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -98.70% | 780.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -98.70% | 780.27% | |||
| Cost of Revenue | -111.61% | 59.91% | |||
| Gross Profit | -96.09% | 9,683.33% | |||
| SG&A Expenses | -8.61% | -12.50% | |||
| Depreciation & Amortization | -4.30% | -16.82% | |||
| Other Operating Expenses | -- | -60.47% | |||
| Total Operating Expenses | -22.92% | -2.25% | |||
| Operating Income | -105.29% | 60.96% | |||
| Income Before Tax | 40.00% | 69.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.00% | 69.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.00% | 69.23% | |||
| EBIT | -105.29% | 60.96% | |||
| EBITDA | -110.68% | 61.92% | |||
| EPS Basic | 42.86% | 95.50% | |||
| Normalized Basic EPS | 32.27% | 87.75% | |||
| EPS Diluted | 42.86% | 95.50% | |||
| Normalized Diluted EPS | 32.27% | 87.75% | |||
| Average Basic Shares Outstanding | 4.96% | 583.77% | |||
| Average Diluted Shares Outstanding | 4.96% | 583.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||